Quasispecies as a matter of fact: Viruses and beyond by Ojosnegros, Samuel et al.
 
 
Since January 2020 Elsevier has created a COVID-19 resource centre with 
free information in English and Mandarin on the novel coronavirus COVID-
19. The COVID-19 resource centre is hosted on Elsevier Connect, the 
company's public news and information website. 
 
Elsevier hereby grants permission to make all its COVID-19-related 
research that is available on the COVID-19 resource centre - including this 
research content - immediately available in PubMed Central and other 
publicly funded repositories, such as the WHO COVID database with rights 
for unrestricted research re-use and analyses in any form or by any means 
with acknowledgement of the original source. These permissions are 
granted for free by Elsevier for as long as the COVID-19 resource centre 
remains active. 
 
R
Q
S
a
b
c
d
a
A
A
D
f
R
r
a
B
K
R
P
M
B
C
P
G
C
2
0
d
Virus Research 162 (2011) 203– 215
Contents lists available at SciVerse ScienceDirect
Virus  Research
jo u r n al hom epa ge: www.elsev ier .com/ locate /v i rusres
eview
uasispecies  as  a  matter  of  fact:  Viruses  and  beyond
amuel  Ojosnegrosa, Celia  Peralesb,c,  Antonio  Masd,  Esteban  Domingob,c,∗
California Institute of Technology, Division of Biology, 1200 E California Blvd, 91125 Pasadena, CA, USA
Centro de Biología Molecular “Severo Ochoa” (CSIC-UAM), Consejo Superior de Investigaciones Científicas (CSIC), Campus de Cantoblanco, 28049 Madrid, Spain
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain
Centro Regional de Investigaciones Biomédicas, Universidad de Castilla La Mancha, Albacete, Spain
 r  t  i  c  l  e  i  n  f  o
rticle history:
vailable online 16 September 2011
edicated to Dr. Brian W.J. Mahy for his
ruitful activity as Editor-in-Chief of Virus
esearch, and for his support to the
esearch on foot-and-mouth disease virus
nd quasispecies carried out at Centro de
iología Molecular Severo Ochoa.
eywords:
a  b  s  t  r  a  c  t
We  review  the  origins  of  the quasispecies  concept  and  its  relevance  for RNA  virus  evolution,  viral  patho-
genesis  and  antiviral  treatment  strategies.  We  emphasize  a critical  point  of  quasispecies  that  refers  to
genome  collectivities  as  the  unit  of  selection,  and  establish  parallels  between  RNA  viruses  and  some  cel-
lular  systems  such  as  bacteria  and  tumor  cells.  We  refer  also  to tantalizing  new  observations  that  suggest
quasispecies  behavior  in prions,  perhaps  as a result  of  the  same  quantum-mechanical  indeterminations
that  underlie  protein  conformation  and  error-prone  replication  in  genetic  systems.  If  substantiated,  these
observations  with  prions  could  lead  to new  research  on  the structure–function  relationship  of non-nucleic
acid  biological  molecules.
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. Introduction: origin of the quasispecies concept
Replication with continuous generation of mutants is a feature
hared by all RNA viruses characterized to date and also at least by
NA viruses whose replication is catalyzed by low fidelity DNA-
ependent DNA polymerases. Until well into the second half of
he XXth century evidence for continuous (rather than occasional)
eneration of mutants during RNA virus replication was  only indi-
ect. For several viruses it was noted that stocks of what should
ave been standard forms of viruses contained unusual amounts
f temperature sensitive (ts) mutants, or that mutant stocks read-
ly reverted towards the wild type phenotypes upon virus passage
several examples were reviewed in Domingo and Holland, 1988;
olland et al., 1982; Horiuchi, 1975).
Also until well into the XXth century, no theoretical treatments
hat dealt with error-prone replication had been developed. Clas-
ical population biology in general did not consider mutation as
 prominent mechanism of variation. The discovery of genetic
olymorphisms in man  and Drosophila (Harris, 1966; Hubby and
ewontin, 1966; Lewontin and Hubby, 1966) came as a surprise
nd led to formulation of mutation-selection equilibrium models
o explain polymorphisms, and contributed to the controversy of
eutralism versus selectionism. As tools of molecular biology pen-
trated into population genetics, the evidence of genetic variation
ecame more and more established. As these events developed,
irology and virus evolution were ignored by population geneti-
ists. As surprising as it may  seem now, in no way replicating
ystems that unavoidably produced mutants at each round of
enome replication were considered as attractive objects to study
volution.
The first mathematical treatment of a replication system with
 regular production of error copies of a template molecule was
y Manfred Eigen in his much quoted treatise published in 1971
Eigen, 1971). That such a quantitative treatment was a necessity
t the time is evidenced by the fact that Francis Crick suggested
o Eigen in a breakfast discussion to undertake the project. Eigen
as also inspired by the experimental work of Sol Spiegelman and
olleagues on serial transfer experiments of bacteriophage Q RNA
sing purified Q replicase. In the transfer experiments Q RNA
anisfested Darwinian behavior (that is, mutation, competition,
nd selection) in vitro (Mills et al., 1967). Eigen’s treatment put
ogether concepts of information theory and Darwinian evolution
o propose a theory of the origin of life based on self-organization of
acromolecules, their replication and adaptability in what might
ave been a primitive RNA world (Eigen, 1971). This theory, termed
uasispecies theory, was further developed by Eigen and Schuster
1979) and has found an important application in the evolution of
NA viruses (Domingo, 2006; Domingo and Wain-Hobson, 2009;
olland, 2006; Lauring and Andino, 2010).
A point of confluence between quasispecies theory and RNA
irus populations is that quasispecies theory proposes that prim-
tive RNA or RNA-like replicons consisted of mutant distributions
mutant spectra or mutant clouds), and this is the type of popula-
ion structure displayed by present day RNA genomes in general.
opulations of RNA viruses were soon shown to be composed
lso of mutant distributions as a consequence of high mutation
nd replication rates, exactly following the pattern of error-prone
eplication that Crick had encouraged Eigen to pursue mathemat-
cally. The initial evidence of quasispecies behavior of an RNA
irus was obtained with bacteriophage Q replicating in its host
scherichia coli, that exhibited high mutation rates and the typi-
al competition and selection dynamics predicted by quasispecies
heory (Batschelet et al., 1976; Domingo et al., 1976, 1978). When
igen learned about the experimental results with bacteriophage
 he did not doubt that they represented an experimental con-
rmation of his theory (for historical accounts of the introductionrch 162 (2011) 203– 215
of quasispecies in virology, see Domingo et al., 2001; Domingo and
Holland, 1988; Domingo and Wain-Hobson, 2009; Holland, 2006;
Holland et al., 1982; Perales et al., 2010).
Quasispecies was  formulated as a deterministic theory that
assumed populations of replicons of infinite size, in equilibrium.
The fact that viral populations are of finite size and rarely in a
true population equilibrium does not imply that quasispecies is not
a good theory to represent virus populations. Indeed, the critical
concept of a population consisting of a mutant spectrum was rep-
resented in the deterministic derivation. Furthermore, extensions
of quasispecies theory to finite populations of replicons under non-
equilibrium conditions (that is, under variable fitness landscapes,
see Section 5 on Fitness) have been derived (Eigen, 2000; Park et al.,
2010; Saakian et al., 2006, 2009; Saakian and Hu, 2006; Schuster,
2010; Wilke et al., 2001). To develop first a deterministic theory
in mathematically solvable terms, and then introduce stochastic
components in it, is a usual procedure in theoretical biology. In fact
the initial deterministic formulation of quasispecies was intended
to framework the self-organization of primitive replicons, that one
cannot easily justify as being in equilibrium when they occurred
some 4000 million years ago (Eigen, 1992).
Quasispecies is not the only theoretical treatment of Darwinian
behavior but the most adequate when high mutation rates char-
acterize the replication system (Page and Nowak, 2002). It has
been emphasized that there is no conflict between quasispecies
and the concept of selection-mutation equilibrium (often termed
Wright–Fisher formulation) (Musso, 2011; Wilke, 2005). It remains
a bit of a mystery why quasispecies rather than other approaches of
population genetics was so successful to penetrate into the study
of viruses at the population level. Among several possibilities that
have been previously outlined (Perales et al., 2010), we think that
the main reason is the direct experimental evidence that RNA
viruses replicate as mutant spectra, a fact that found its best concep-
tualization in quasispecies theory. Also, the presence of a mutant
spectrum established an immediate connection with problems of
viral disease control. Indeed a mutant spectrum readily explained
the high frequency of escape mutants to many selective constraints
intended to inhibit viral replication (Domingo, 1989; Domingo and
Holland, 1992). The connection with control of virus disease was
more distant and less intuitive with other theoretical treatments of
population genetics.
It has been also previously commented how inadequate (due
to an implied oversimplification) it is to refer to components of
a mutant spectrum as alleles, and to a quasispecies structure as
genetic polymorphism, at least if we  adhere to the original defini-
tions of allele and polymorphisms in genetics (Domingo et al., 2001;
Perales et al., 2010; Spiess, 1977). Terminology might be regarded
as secondary provided the type of population structure of viruses
to be confronted is well understood (Perales et al., 2010). Virolo-
gists presently use the term quasispecies to mean distributions of
non-identical but related genomes subjected to a continuous pro-
cess of genetic variation, competition, and selection, and which act
as a unit of selection (Domingo, 2006; Perales et al., 2010).
Following the Q work, quasispecies dynamics was docu-
mented with foot-and-mouth disease virus in cell culture and
in vivo (Domingo et al., 1980; Sobrino et al., 1983), including the
concept that antigenic heterogeneity was a consequence of genetic
heterogeneity (Mateu et al., 1987, 1988, 1989; review in Domingo
et al., 2003). In parallel, Holland and his colleagues interpreted
the competition-selection dynamics between vesicular stomatitis
virus (VSV) and their corresponding defective-interfering (DI) par-
ticles in the light of high mutation rates and quasispecies dynamics
(Holland, 1984; Holland et al., 1982; Semler and Holland, 1979;
Spindler et al., 1982). The studies with VSV established important
connections between classical concepts of population genetics (the
Red Queen hypothesis, the competitive exclusion principle, fitness
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ariations, etc.) and RNA virus evolutionary dynamics (reviewed in
ovella, 2003).
In the present article, we first describe experimental approaches
o the study of viral evolution, then we summarize some of the most
triking behaviors described for RNA viruses in cell culture, and the
onnection of findings with observations in vivo. Finally we  explore
he application of quasispecies to non-viral systems.
. Experimental approaches to virus evolution
.1. The experiment as an answer or as a question
An interesting feature derived from the rapid diversification of
NA viruses is the production of diverse, and often unusual col-
ections of phenotypes (not only genotypes) during cell culture
xperiments in a time-scale observable in the laboratory. Several
esearch groups have made use of this property of RNA virus biology
o learn about evolution by means of two main approaches. The first
pproach aims at describing the molecular mechanisms underly-
ng viral replication and variation, and their consequences for virus
daptability. The virus itself is the object of the investigation. In
 second approach, RNA viruses are considered model organisms,
nd are used to test classical evolutionary theories, mainly those
hat originated in population genetics, and that would benefit from
n experimental validation. In the first approach, the experiment
tself is the question, and the observed viral response would provide
he answer. The second approach starts with a predefined ques-
ion or hypothesis and the experiment provides the answer. Both
pproaches are complementary, and have provided new insights
n virus evolution and in general evolution, although in the present
eview we will focus mainly on the first experimental approach.
.2. The experiment as a question
Variability of RNA virus populations underlies some of the major
roblems related to their pathogenic potential. The width of the
utant spectrum has been associated with severity of hepatitis C
irus (HCV)-associated disease, and response to antiviral treatment
Domingo and Gomez, 2007; Farci et al., 2000; Le Guen et al., 1997;
opez-Labrador et al., 1999; Mas  et al., 2004; Morishima et al., 2006;
in et al., 2005; Rothman et al., 2005), the progression of human
mmunodeficieny virus (HIV) infection to AIDS (Nowak et al.,
991), or with poliovirus neurovirulence (Pfeiffer and Kirkegaard,
005; Vignuzzi et al., 2006). Quasispecies diversity ensues from the
ction of error-prone polymerases, recombination events, genome
egment reasortment, complementation, and a number of other
olecular mechanisms (Domingo et al., 2006). Research on the
mpact of mutation rates and population heterogeneity on virus
daptability and survival should benefit available polymerase
delity mutants of picornaviruses (Pfeiffer and Kirkegaard, 2005;
ignuzzi and Andino, 2010; Vignuzzi et al., 2006) and coron-
viruses with either an active or inactive proofreading-repair
ctivity (Denison et al., 2011; Eckerle et al., 2007, 2010; Levi et al.,
010). Because RNA viruses typically produce large numbers of
rogeny in relatively short time periods, the diversity generated by
hose mechanisms is explosively amplified leading to a competition
etween multitude of different variants and the selection of some
f them in the classical Darwinian way. It must be stressed that an
nvariant consensus sequence does not mean absence of mutations.
ather, it means that the mutations that occur at the usual rate
f 10−3 to 10−5 substitutions per nucleotide copied (Batschelet
t al., 1976; Drake and Holland, 1999; Sanjuan et al., 2010) when
omponents of the mutant spectrum replicate, lead to the same
onsensus. Quasispecies populations are thus complex systemsrch 162 (2011) 203– 215 205
with a tremendous capacity to evolve, and our knowledge of these
adaptative mechanisms is still fragmentary (Manrubia et al., 2005).
Although classical theories may  constitute a good starting point
to study virus evolution, a predefined hypothesis that may  oper-
ate during the evolution of DNA organisms, may not apply to more
complex systems such as RNA virus populations. It is actually not
unusual that established concepts of DNA evolution fail to match
the results obtained from experiments with RNA viruses (Froissart
et al., 2010; Holland et al., 1982; Sacristan et al., 2005). New theories
built upon experimental observations are needed to complete the
whole picture of RNA virus evolution. Research in our laboratory
has often involved repeated passages of virus clones in cell culture
(Fig. 1), a simple protocol which favors competition among variants,
and the rescuing of interesting phenotypes, impossible to predict a
priori. By using appropriate and contrasting passage regimes, com-
bined with molecular biology techniques, in some cases it has been
possible to find the mechanisms leading to unusual phenotypes.
2.3. Dynamics of fitness variation
Viral fitness has been typically treated as a relative parameter
that quantifies the replication capacity of a virus relative to some
reference isolate, in a given environment (Domingo and Holland,
1997; Martinez-Picado and Martinez, 2008; Quiñones-Mateu and
Arts, 2006). Fitness is usually measured in a competition between
the virus to be tested and a reference variant in cell culture or
in vivo, and its value has been equated with that of a selection
coefficient (Maree et al., 2000). It is important to note that fit-
ness values are relative and environment-dependent. Fitness of a
HIV-1 variant determined by growth-competition experiments in
PBMCs does not necessarily reflect the fitness that the same iso-
late will have in an infected patient. Fitness of viruses in vivo is a
determinant of viral load and the latter is often one of the corre-
lates of disease severity (Mellors et al., 1996; Mueller et al., 2008;
Srikiatkhachorn and Green, 2010). Thus, despite the complications
encountered, fitness determinations in vivo could help predicting
the disease potential of viruses (Carrillo et al., 1998). Even in the
course of fitness determinations in cell culture, a mutant cloud is
generated around the clonal population used for the assay. This
introduces an additional indetermination regarding the behavior
of the competing populations (Domingo and Holland, 1997).
One of the first observations derived from passaging viruses
sequentially in cell culture was that when a virus was allowed to
replicate at high multiplicity of infection (MOI) (high viral inocu-
lum), the whole population tended to increase its fitness in an
exponential manner (Escarmís et al., 1999; Novella et al., 1995).
In contrast, when viruses were passaged in a regimen consisting
of sequential bottleneck events, the fitness of the virus dropped
drastically (Fig. 1). Fitness loss of asexual populations was already
predicted by Muller (1964) and first confirmed experimentally with
bacteriophage 6  (Chao, 1990).
In detailed experiments carried out with foot-and-mouth dis-
ease virus (FMDV), several viral clones were extensively passaged
in series of up to 300 bottleneck, or plaque-to-plaque transfers
(Escarmís et al., 1996, 1999, 2002, 2008, 2009). The virus fitness
decreased rapidly during the first passages, but afterwards the virus
fitness oscillated around a constant average value during roughly
300 passages. Several unusual mutations and extreme phenotypes
were obtained upon subjecting FMDV clones to hundreds of plaque-
to-plaque transfers. It is worth mentioning the evolution towards
non-cytocidal forms of FMDV that could establish a persistent infec-
tion in cell culture (Escarmís et al., 2008), without an initial phase of
cytopathology. The latter was necessary for the wild type FMDV to
establish persistence in a few surviving cells (de la Torre et al., 1985;
Herrera et al., 2008), but not for the evolved, non-cytopathic clones.
In each plaque-to-plaque transfer a single infectious genome from
206 S. Ojosnegros et al. / Virus Research 162 (2011) 203– 215
Fig. 1. (A) Schematic representation of sequential viral infections in cell culture. High MOI  infections are carried out with undiluted samples from the supernatant of the
previous infection. Low MOI  or plaque-to-plaque transfers are carried out by diluting virus from individual lysis plaques, and transferring the virus to the next plate. (B)
Fitness  and virulence variations in viral populations. Serial passages of a virus involving a large population size per passage result in increased replication capacity and fitness
gain  (triangle). In contrast, repeated bottleneck events lead to fitness decrease. This part of the scheme is based on studies in several laboratories discussed in the text. In
a  comparative study of the evolution of virulence values of foot-and-mouth disease clones subjected to bottleneck events, virulence (trapezium) did not follow the same
trajectory than fitness, and the molecular basis of the different trajectories was  elucidated (Herrera et al., 2007). However, the relationship between fitness and virulence
can  be more complex, and its discussion is beyond the scope of the present article (see text for the influence of quasispecies organization as a determinant of virulence in
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ome  of which carry a lethal (or highly disadvantageous) mutation (*), and the corr
ncorporating this (or other) “toxic” proteins will have their fitness affected even if 
he mutant spectrum is amplified to generate the virus populations
n the ensuing plaque. Thus, the multiple and extreme genotypes
nd phenotypes identified in the studies on bottleneck passages of
MDV testify the incredible diversification potential of RNA viruses
Fig. 1).
Bottleneck events are probably abundant during the life cycle
f viruses in their infected hosts (Ali et al., 2006; Betancourt et al.,
008; Domingo et al., 2008; Escarmís et al., 2006; Foy et al., 2004;
aaland et al., 2009; Li and Roossinck, 2004; Quer et al., 2005,
008; Scholle et al., 2004; Smith et al., 2008). Given what we know
ow of the complexity of mutant spectra, it is necessary to fur-
her investigate the consequences of bottleneck events of different
ntensities when they occur within infected host organisms. How-
ver, bottlenecks are not the only mechanisms to unveil altered
henotypes. Equally rich mutant spectra are generated upon large
opulation transfers, sometimes with striking consequences, as
iscussed next.
. Interactions within mutant spectra
One of the most unexpected but also attractive findings in recent
ears has been that mutant spectra often do not act as indepen-
ent collections of mutants, but rather as interacting sets of variant
iruses subjected to group selection. These observations not only
einforce the concept of quasispecies as the unit of selection but
lso offer prospects of new research avenues in which the behaviorolecular interference. The viral particle depicted in green has generated progeny
ding altered protein can be shared among its different competing mutants. Viruses
utation is not present in their genome.
of viruses is dictated not by individuals but by connected sets of
individuals. Here we underline some of these observations.
3.1. The competition-colonization trade off
The RNA virus literature includes several instances of the influ-
ence of the multiplicity of infection (MOI) on the evolution of a
virus. Viruses adapted to replicate at high MOI  will outcompete
viruses adapted at low MOI  when the competition takes place under
high MOI  conditions. The opposite is true in competitions under
low MOI  conditions (Sevilla et al., 1998; Turner and Chao, 1999).
This kind of density-dependent selection suggests that RNA viral
genomes may  behave differently when they are rare or when they
are abundant in a population (Novella et al., 2004). Since any tissue
or cell culture is a discrete resource (that is, composed of individ-
ual cells), the viruses can adapt to compete either for the whole cell
pool or locally within a single cell. When different viruses coinfect
the same cell, a local competition is established. The replication
of a variant of the population can interfere with the replication of
another one, even if both variants are close in sequence space (the
two genomes differ in a limited number of mutations). The degree
of interference exerted can range from a simple competition for
the resources with coexistence of the two competitors, to an almost
complete abolition of replication of one of the competitors, as in the
case of some defective viruses (Holland, 1990; Roux et al., 1991).
The rationale for the existence of interference among viral mutants
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s that viruses share, with a variable degree, their genetic products
nd cell resources in coinfected cells. When a dominant negative
utant arises (also referred to as defector or cheater) it finds the
uitable molecular environment to progress.
Replication-interference mechanisms have been described in a
ange of different DNA and RNA viruses. Among other phenotypes,
hese processes include the suppression of high fitness viruses
y lower fitness mutants documented with VSV (de la Torre and
olland, 1990), density-dependent selection of VSV (Novella et al.,
004), the snow drift type of replication of RNA phage 6  (Turner
nd Chao, 1999, 2003), the antigenic exchange between coinfect-
ng mutants called phenotypic hiding, documented for VSV and
nfluenza virus (Holland et al., 1989; Valcarcel and Ortin, 1989),
uppression of virulent poliovirus by its corresponding attenuated
ariants (Chumakov et al., 1991) or suppression of the growth hor-
one deficiency syndrome induced by some strains of lymphocytic
horiomeningitis virus (LCMV) by disease-negative LCMV variants
Teng et al., 1996), and finally, an innumerable list of defective virus
ypes (Holland, 1990).
A recent study has suggested that the difference between the
ocal competition in coinfected cells and the competition for the
hole cell pool, can lead to the diversification of a single, purified
MDV clone into competitor and colonizer phenotypes (Ojosnegros
t al., 2010a).  Colonizers are virulent strains adapted to replicate
aster and spread faster through the cell culture. At low MOI, colo-
izers were selected because they quickly took over the unoccupied
ulture (susceptible cells). At high MOI, at which local competi-
ion in multiply infected cells is frequent, competitors succeeded
ecause of their higher interference capacity or intracellular fitness
Ojosnegros et al., 2010b).  The selection of either type followed
 dynamic density-dependent selection, a highly non-linear pro-
ess, in agreement with previous observations on the lack of direct
orrelation between fitness and virulence (Herrera et al., 2007)
Fig. 1). These studies stress the importance of confections and the
nteraction among components of mutant spectra in shaping the
irulence of viral populations. Natural variation of virulence in vivo
ay  partly stem from interactions among viral subpopulations, a
ossibility which remains largely unexplored. An extension of the
ompetition-colonization model simulates continuous infections,
he scenario of real infections where susceptible cells are replen-
shed instead of being exhausted as in cell culture systems. The
odel stresses, in a quantifiable manner, that the realistic val-
es of variable MOI  taking place in an infection can account for a
igh degree of interaction and even attenuation of viral infections
Delgado-Eckert et al., 2011).
.2. Extreme case of complementation
Following our preferred approach, simply by allowing an FMDV
lone to replicate serially in cell culture at high MOI, we described
he evolution of the virus towards a population dominated by
efective genomes that were infectious by complementation, a
emarkable evolutionary transition (Garcia-Arriaza et al., 2004,
006). The viral population resembled segmented multipartite
iruses (i.e. brome mosaic virus) where each segment is packaged in
 single capsid. After performing a battery of experiments involving
he analyses of different steps of the virus life cycle, our obser-
ations indicated that particles harbouring smaller genomes were
ore stable and had longer life spans than particles with the full
ength genome (Ojosnegros et al., 2011). The segmented genomes
ecame dominant in the population spontaneously without any
enome engineering or experimental intervention. Increasing evi-
ence from different virus families indicates that viral genomes are
ightly packaged in their capsid shells (Gelbart and Knobler, 2009),
nd that capsid density may  be inversely related to the stability of
he particle (De Paepe and Taddei, 2006). In agreement with theserch 162 (2011) 203– 215 207
mechanistic studies, our results provide an experimental proof for
the potential evolutionary benefit of increasing particle stability
which represents a completely new theory for the evolution of
segmented genomes (Ojosnegros et al., 2011).
The study of the segmented population of FMDV led to the
design of an immunization protocol using the segmented viruses
as vaccines that share features of inactivated and live-attenuated
vaccines (Rodriguez-Calvo et al., 2010). The requirement of comple-
mentation for replication renders the infection self-limiting. The
inoculation point may  have the necessary high MOI  conditions
for the different segments to complement. However, after dilu-
tion through diffusion in cells next to the inoculation site and then
in the blood, the probability of two  particles hitting the same cell
drops drastically (Manrubia et al., 2006). The preliminary vacci-
nation tests included immunization of mice susceptible to FMDV
infection and achieved 100% protection against lethal doses of the
wild type virus. The immunization of swine, the FMDV natural host,
induced high titers of both FMDV-specific neutralizing antibodies
and activated FMDV-specific T cells in swine which correlated with
solid protection against FMDV (Rodriguez-Calvo et al., 2010). Thus,
virus evolution may  inspire new approaches to vaccine design. This
statement applies to antiviral drugs too.
4. Quasispecies and antiviral therapy
To underline concepts discussed in Section 2, genetic variability
and population dynamics of highly variable RNA viruses are one
of the main obstacles for prevention and control of the diseases
associated with them (Domingo, 1989; Figlerowicz et al., 2003).
Quasispecies dynamics of viral populations, that results in virus
escaping the inhibitory activity of antiviral inhibitors due to the
selection of drug-resistant viral mutants, is one of the key issues
that has to be taken into account for the planning of antiviral
strategies. The systematic selection of drug-escape mutants has
promoted research on lethal mutagenesis as an antiviral strat-
egy whose objective is to extinguish virus through an increase in
mutation rate, thereby counteracting the adaptive capacity of RNA
viruses. Several studies in cell culture and in vivo have supported
lethal mutagenesis as a viable antiviral strategy (Anderson et al.,
2004; Domingo, 2005; Eigen, 2002; Graci and Cameron, 2008), and a
clinical trial in which a mutagenic pyrimidine analogue was  admin-
istered to AIDS patients has been recently reported (Mullins et al.,
2011).
A better understanding of the molecular basis of viral replication
and of lethal mutagenesis should help unveiling new therapeutic
targets both for mutagenic and non-mutagenic agents. An essen-
tial feature of quasispecies dynamics is that the quasispecies as a
whole, rather than an individual genome, is the target of selec-
tion. Quasispecies represents the recognition of complex behavior
of viruses having important implications for RNA virus adaptabil-
ity and their pathogenic potential. Quasispecies complexity and
composition may  affect the response to antiviral treatments.
The behavior of mutant spectra as an ensemble is influenced by
complementation and interference that are exerted among its indi-
vidual components. Interference is believed to be exerted mainly
through altered gene products that produce non-functional pro-
tein complexes during the virus life cycle (reviewed in Domingo,
2006; see also Section 3). Precisely the mastering of these nega-
tive interactions may  determine the success of lethal mutagenesis
as an antiviral therapy, since an excess of negative interfering
interactions is one of the mechanisms likely to contribute to virus
extinction by lethal mutagenesis (González-López et al., 2004;
Grande-Pérez et al., 2005b; Iranzo and Manrubia, 2009; Perales
et al., 2007). These studies demonstrated that in the transition
towards extinction, mutagenized, preextinction FMDV populations
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corresponding to virus from the passage that precedes the one
n which the virus goes extinct) interfered with the infectivity
f standard FMDV RNA, resulting in a decrease in the produc-
ion of progeny virus (González-López et al., 2004). It was  also
hown that the decrease of virus infectivity preceded the decrease
f viral RNA in the infected cells, suggesting an increased con-
entration of defective genomes in the mutagenized population
Grande-Pérez et al., 2005b). This observation is in agreement with
he decrease in specific infectivity (the ratio of PFU to the num-
er of viral RNA genomes) generally observed in the transition of
iruses towards extinction (Domingo et al., 2008). Interference by
pecific FMDV mutants was further documented in RNA coelec-
roporation experiments with wild type and capsid or polymerase
MDV mutants (Perales et al., 2007). The results showed that an
xcess of several replication-competent mutants caused a strong
nd specific interference on FMDV replication. Moreover, mixtures
f some capsid and polymerase mutants evoke a very strong, syn-
rgistic interference, supporting the notion that, as the proportion
f mutant genomes increases as a result of mutagenesis, interfer-
ng mutant genomes can contribute to virus extinction. The results
videnced also that a single amino acid substitution can be respon-
ible for rendering a non-interfering genome interfering, and vice
ersa (interfering and non-interfering genomes can be neighbors in
equence space). Thus, negative interactions (interference) among
omponents of a mutant spectrum (through trans-acting, altered
ene products) may  be attained through modest increases in muta-
ional load (Grande-Pérez et al., 2005b; Ojosnegros et al., 2008), and
ay  participate in virus extinction, in support of the lethal defec-
ion model of extinction. Trans-acting mutants of poliovirus were
hown to delay replication of drug-resistant poliovirus mutants
Crowder and Kirkegaard, 2005; Spagnolo et al., 2010) (Fig. 1).
The presence of the nucleoside analogue ribavirin during viral
eplication enhanced the interfering activity of some specific FMDV
utants, presumably because ribavirin may  contribute to the gen-
ration of additional defector genomes. In contrast, the presence of
n inhibitor of the viral replication such as guanidine hydrochloride
GU) suppressed the interference exerted by the defectors mutants
Perales et al., 2009b). This important point is still under investiga-
ion, but current evidence suggest that these events are probably
nfluenced by the dynamics of mutagenesis versus inhibition dur-
ng viral genome replication, and also because GU impeded the
eplication of defector genomes, and diminished their interfering
ctivity. Thus, current evidence suggests that interfering activity is
mportant to drive the population towards extinction.
The administration of virus-specific mutagenic base or nucle-
side analogues requires careful consideration of protocols when
ntiviral inhibitors are coadministered with the mutagenic agents.
o optimize antiviral protocols that take into account these
equirements, different treatment protocols were compared. FMDV
as extinguished by the combined (simultaneous) or sequential
dministration of mutagenic agents and antiviral inhibitors, and
xtinction occurred with a decrease of the specific infectivity of
he virus, and without alteration of the consensus sequence of
he population (Domingo et al., 2008; González-López et al., 2005;
rande-Pérez et al., 2005a).  However, our recent results suggest
hat when a mutagenic agent is involved in an antiviral treatment,
 sequential administration first of the inhibitor and then of the
utagen may  be more effective than the corresponding combi-
ation treatment. The advantage of such sequential therapy has
een supported by experiments in cell culture and by a theoretical
odel for the evolution of a viral population under the action of
ncreased mutagenesis in the presence of an inhibitor of viral repli-
ation (Perales et al., 2009b).  The understanding of the interplay
etween mutagenesis of the viral genome and inhibition of viral
eplication is needed for the design of treatment protocols aimed at
educing the viral load or eliminating the virus from infected cells.rch 162 (2011) 203– 215
Viral population size influences the selection of inhibitor-escape
mutants. The administration of a non-mutagenic inhibitor first in a
sequential therapy may  result in a sufficiently low viral replicative
load that may  prevent the selection of inhibitor-escape mutants
(Perales et al., 2011a). Then, the subsequent administration of a
mutagenic agent may  generate defector mutants that interfere with
the infectivity of wild type virus, and lead to the collapse of the
replicative system. In contrast, in a combination therapy the simul-
taneous administration of both drugs increases the probability of
selection of inhibitor-escape mutants due to the mutagen-induced
error rate. Additionally, interfering mutants generated by the muta-
gen that contribute to extinction, may  not be active in the presence
of an inhibitor (Perales et al., 2009b).
Recently, the theory underlying the interaction between a
mutagenic agent and antiviral inhibitor has been developed in
connection with the relative advantage of sequential versus com-
bination antiviral treatments (Iranzo et al., in press). In silico
simulations can predict the response of a viral population to dif-
ferent doses of inhibitor and mutagens, and how to minimize the
probability of appearance of resistant mutants. Drug doses largely
determine the suitability of a sequential versus combined admin-
istration of a mutagen and an inhibitor. Application of this new
theoretical model may  reduce the number of experiments prior to
the implementation of a treatment protocol based on lethal muta-
genesis (Iranzo et al., in press).
4.1. Drug-resistant viral mutants
The rapid emergence of drug-resistant viral mutants is a gen-
eral observation, to the point that such a selection is considered
evidence of the specificity of the antiviral drug. The ease of selec-
tion of many resistant variants originates in quasispecies dynamics
and it is favored by the pre-existence of the relevant mutants in the
corresponding mutant spectra (Nájera et al., 1994, 1995, and many
other examples documented since then).
Mutagenic agents are not an exception and selection of
mutagen-resistant viruses may  impede the extinction of the viral
population. RNA viruses display different mechanisms of resis-
tance to mutagenic nucleotide analogues as most clearly evidenced
with resistance to ribavirin (Agudo et al., 2010; Arias et al., 2008;
Castro et al., 2005; Pfeiffer and Kirkegaard, 2003; Sierra et al., 2007;
Vignuzzi and Andino, 2010; Vignuzzi et al., 2006). When domi-
nant in a population, a mutation that confers partial resistance
to a mutagenic agent can jeopardize virus extinction by elevated
doses of the same mutagen. However, we  have demonstrated that
a mutagen-resistant variant could still be driven towards extinction
by a combination treatment involving another mutagen and a non-
mutagenic antiviral inhibitor (Perales et al., 2009a). Thus, there are
positive prospects that alternative inhibitors and mutagenic agents
used sequentially or in combination could be used in clinical trials,
following the footsteps of Loeb, Mullins and colleagues (Mullins
et al., 2011).
4.2. Diving into mutant spectra in search of minority genomes
Appropriate methods to quantify the variability of RNA viruses
include analyzing mutant spectrum by molecular cloning and
sequencing, and more recently by using new molecular approaches
such as ultra deep nucleotide sequencing (Domingo, 2006;
Domingo and Wain-Hobson, 2009; Garcia-Arriaza et al., 2007;
Lauring and Andino, 2011; Mardis, 2008; Mas et al., 2010; Perales
et al., 2010; Webster et al., 2009; Wright et al., 2011; Zagordi
et al., 2010). Despite a number of relevant publications that have
used ultra deep sequencing for quasispecies analysis (reviewed
in Djikeng and Spiro, 2009; Perales et al., 2010) it is important
to note that appropriate correcting algorithms must be used to
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xclude artefactual mutations due to the amplification and analyt-
cal procedures (Eriksson et al., 2008; Zagordi et al., 2010). When
orrections are applied, accurate descriptions of mutant spectra
an be achieved, and they are currently confirming the genetic
omplexity of viral populations in vivo.
Ultra deep sequencing analysis has enabled the identifica-
ion of low-frequency mutations present at baseline (preexisting
utants), before drug exposure that confer resistance to protease
nhibitors for HCV (Verbinnen et al., 2010), among other examples.
 critical issue now is whether an application of ultra deep sequenc-
ng will become cost-effective regarding treatment planning.
Other procedures have been developed to penetrate into the
omposition of mutant spectra. Differential PCR amplifications
ave been developed for the detection and quantification of
inority viral subpopulations (Garcia-Arriaza et al., 2007). Heav-
ly mutagenized minority components generated as a result of R
utagenesis have been analyzed by differential DNA denaturation
CR (3D-PCR) that permits the selective amplification of AU-rich
ypermutants produced by R mutagenesis, by modulating the PCR
enaturation temperature (Suspène et al., 2005). The analysis of
n A,U-rich portion of the genomic sequence space unveiled a
eep mutant spectrum complexity not only of FMDV populations
assaged in the presence of R, but also in its absence reinforcing
he concept that the virus replicates close to an error threshold
or maintenance of genetic information (Perales et al., in press).
nterestingly, the major effect of R mutagenesis was  to accelerate
he occurrence of A,U-rich mutant clouds during the early repli-
ation rounds of the virus. A previously characterized R-resistance
olymerase mutation (P44S) (Agudo et al., 2010) was present in
he mutant spectrum of an FMDV not treated with ribavirin. This
esult in cell culture extends previous evidence of the presence
f inhibitor-resistance mutations in natural viral isolates infect-
ng patients who had never been treated with the corresponding
nhibitors (Section 4.1). The substitution that confers resistance to
ibavirin increased in frequency as the population was confronted
ith R, and this selective 3D-PCR amplification procedure has
evealed additional substitutions as possible candidates to confer
esistance to the drug. The application of differential amplifica-
ions have opened the possibility to characterize molecularly new
efector subpopulations of RNA viruses that contribute to virus
xtinction by lethal mutagenesis, as well as to detect the presence
f hypermutated genomes, that might occur in the transition into
rror catastrophe (Perales et al., in press).
. Fitness of individuals, fitness of groups of individuals.
ell collectivities as a model
Most of the events that preside quasispecies dynamics can be
raced to selection of viral subpopulations, that acquire a selective
dvantage as a result of an environmental change, or to subpopula-
ions that separate from their ensemble as a result of a bottleneck
vent (Fig. 1). In addition, several features of viral quasispecies sup-
ort the concept of a mutant ensemble being the target of selection
n viruses. In our laboratory, this concept was tested experimentally
y reconstructing a mutant distribution using nineteen antigenic
ariants of FMDV. The results showed that an ample representa-
ion of variants (and not an individual genome) was selected by a
pecific antibody, underlying the behavior of the quasispecies as
n entire collection of mutant viruses (Perales et al., 2005). The
elevance of the composition of the mutant spectrum was also doc-
mented with the presence of a molecular memory in quasispecies,
hich means the maintenance as minority components of genomes
hich are closely related to those that were dominant at an ear-
ier phase of the same evolutionary lineage (Briones and Domingo,
008; Ruiz-Jarabo et al., 2000). Memory confers preparedness torch 162 (2011) 203– 215 209
a  viral population to respond to a selective constraint previously
experienced by the same viral population.
As discussed in Section 3, the implication of quasispecies theory
that an ensemble is the target of selection (Codoner et al., 2006;
Eigen, 1971; Eigen and Biebricher, 1988; Eigen and Schuster, 1979;
Schuster, 2010) may  be at times realized through complementing
or interfering interactions. The question arises whether such qua-
sispecies behavior exists in other biological systems (Mas et al.,
2010).
The unit of natural selection is one of the most basic, com-
plex and debated questions of evolutionary biology (Mayr, 1997).
According to one of the current views, if the fitness of a group is
higher that the arithmetic mean of the fitness values of the com-
posing individuals, then the group as a whole can serve as a unit
of selection. The difference in favor of the fitness of a group may
be due to the interaction among the individuals that compose the
group, to a division of labor, or other social actions (Mayr, 1997).
Thus, an interaction among components of a mutant spectrum in a
RNA virus quasispecies implies that the individuals must be linked,
so that the entire population forms a cooperative structure that
evolves as a single unit (Lauring and Andino, 2010). In this context,
the social Darwinism model developed by Spencer (1876) was the
first to cite the term “superorganism” in relation to a social organi-
zation. The term superorganism is often mentioned in relation to
eusocial animals, that show a specialized division of labor, and indi-
viduals are not able to survive by themselves for extended periods
of time (Queller and Strassmann, 2003). In this case, social actions
or division of labor could be regarded as analogous to the interac-
tion of the individuals (complementing interactions) described for
RNA virus quasispecies (see Sections 3 and 4).
5.1. Collective behavior in bacteria
The tendency of individuals to act in a collective fashion has
been increasingly evidenced for microbes generally (Foster, 2011).
It is now recognized that bacteria very frequently do not exist as
solitary cells, but as colonial organisms that exploit elaborate sys-
tems of intercellular communication to facilitate their adaptation
to changing environmental conditions. Social behavior related to
antibiotic production, virulence, motility or biofilm formation has
been extensively described (Rumbaugh et al., 2009). Much of the
social behavior of bacteria is regulated by cell-to-cell signals in a
cell density-dependent manner known as quorum-sensing (Fuqua
et al., 1994; Miller and Bassler, 2001; Nealson and Hastings, 1979).
Quorum sensing is based on a two-component signal transduction
phosphorelay scheme that allows microorganisms to sense the cell
density, and produce a coordinated response as a whole population.
Intrapopulation diversity in bacteria may  result in higher levels of
cooperation and modulation of virulence, as previously described
for RNA virus quasispecies (Ojosnegros et al., 2010a,b; Vignuzzi
and Andino, 2010; Vignuzzi et al., 2006). In fact, recent studies on
the role of quorum sensing during infections support this hypothe-
sis, and show that cooperative interactions can modulate virulence
levels in bacteria. It is interesting that in mono-strain infections,
the bacteria that do not participate cooperatively in quorum sens-
ing (cheats or defectors as in the lethal defection model of RNA
viruses, see Section 4) are significantly less virulent, and are more
readily cleared by the immune system or by antibacterial inter-
ventions. However, during a mixed infection with a cooperating
strain, the cheat has a fitness that exceeds that of the cooperating
strain (Rumbaugh et al., 2009). This suggests that during in vivo
infections, quorum sensing mutants can exploit the products of
cooperators. The overall implication is that the spread of cheats
within a population can significantly reduce virulence due to a
breakdown in cooperation. Therefore, in addition to the infection
being less virulent, these mixed infections may  be easier to treat
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ith conventional antimicrobial therapies (Rumbaugh et al., 2009).
ethal mutagenesis of viruses can be viewed also as a cooperation
ailure, and it is the basis of the new antiviral treatment discussed
n Section 4 (Perales et al., 2009b, 2011a).
Biofilm formation has been also viewed as a manifestation of
acterial social behavior. Biofilms are communities of microorgan-
sms that assemble within an extracellular polymeric slime matrix
Costerton et al., 1978). Some examples of biofilms are those formed
y Pseudomonas aeruginosa,  Legionella or Neisseria gonorrea, or the
ental plaque. These organic super-structures have important clin-
cal implications as infectious agents (Costerton et al., 1978, 1987,
999). The microbial cells growing in a biofilm are highly heteroge-
eous and physiologically different from the constituent cells when
oating or swimming in isolation in a liquid medium (Stewart and
ranklin, 2008). In addition, the mechanisms that confer antibiotic
esistance in biofilms seem to be different from those based on
lasmids, transposons, or mutations that confer innate resistance
o individual bacterial cells (Stewart and Costerton, 2001). Different
ypotheses for antibiotic resistance of biofilms have been proposed
ncluding limited diffusion of the antibiotic within the biofilm,
ltered chemical microenvironment, or the presence of subpopu-
ations of microorganisms that form a unique and highly protected
henotypic state (Stewart and Costerton, 2001). These multiple
esistance mechanisms are not mutually exclusive and therefore,
ntibiofilm therapies might have to address more than one mech-
nism simultaneously to be clinically effective. The existence of
ubpopulations with different and well defined phenotypes inside
he biofilm resembles the heterogeneity described for RNA virus
opulations. Furthermore, biofilms have been also proposed as the
arget of evolutionary selection (Caldwell and Costerton, 1996), in
 clear parallel with viral quasispecies.
One strategy proposed to combat biofilms is based on infection
y bacteriophages. However, infection could contribute to biofilm
ispersal and selection of morphotypic bacterial variants. It has
een recently reported for P. aeruginosa and Pf4 bacteriophage that
utant biofilms that lack the phage are less virulent than the wild
ype (Rice et al., 2009), emphasizing again the highly complex orga-
ization of such communities.
.2. Heterogeneity and group behavior in cancer cells
Genomic mutation rates of RNA viruses are extremely high and
o not have a parallel in cells under normal physiological con-
itions, except in localized functional hypermutations such as in
eneration of immunoglobulin diversity. However, eukaryotic cells
an achieve high levels of heterogeneity by mechanisms other than
hose used by viruses (Snijder and Pelkmans, 2011; Snijder et al.,
009). Cellular heterogeneity lies at the basis of important clin-
cal disorders such as cancer which can be defined as a genetic
isease. Groups of cells display uncontrolled growth, invasion of
djacent tissues, and sometimes metastasis (invasion of distant tis-
ues) (Boveri, 1914; Hanahan and Weinberg, 2011; Hansemann,
890). To achieve these properties, cancer cells change their genetic
nformation through point mutations in their DNA, chromoso-
al  rearrangements and/or epigenetic modifications (Hanahan and
einberg, 2011). Mutations in cellular DNA are more frequent in
umor cells than in normal cells. A mutator phenotype of cancer
ells could act as an evolutionary motor to increase the probability
f finding the most advantageous phenotype for tumor growth and
ispersal (Bielas et al., 2006; Loeb, 2001; Nicolson, 1987). The cel-
ular machinery for deamination has been recently linked to this
utator phenotype (Vartanian et al., 2008). Multiple mutationsffecting proteins involved in DNA binding, transcriptional regula-
ion, or cellular signaling have been related to cancer (Futreal et al.,
004). They often result either in the gain of an oncogene or the
oss of a tumor suppressor.rch 162 (2011) 203– 215
Identification of mutations involved in cancer development,
together with high-throughput sequencing technologies (ultra-
deep sequencing) are currently active fields of research and may
lead to a better understanding of cancer complexity (Chin et al.,
2011), again in sharp parallel with mutant spectrum complexity
of viruses (Section 4). High frequency mutations involving onco-
genes or tumor suppressors are usually accompanied by a complex
combination of low-frequency changes, and these mutations can
contribute to the phenotypic traits of cancer cells (Greenman et al.,
2007). These facts indicate that cancer behaves as a complex system
that displays high heterogeneity and clonal evolution (Deisboeck
and Couzin, 2009; Nowell, 1976). The system evolves through
mutations and epigenetic changes, following Darwinian principles
of competition and selection (Maley and Forrest, 2000; Merlo et al.,
2006). Maley et al. (2006) have described that clonal diversity in
cancer cells could be used as a factor for predicting progression in
an esophageal adenocarcinoma cancer model.
Theoretical studies have correlated genetic instability in can-
cer cells (Gonzalez-Garcia et al., 2002; Maley and Forrest, 2000)
with quasispecies models of minimal replicators (Brumer et al.,
2006; Tannenbaum et al., 2006), and with the implementation of
the error catastrophe concept in cancer (Fox and Loeb, 2010; Solé
and Deisboeck, 2004). All these studies point to the high genetic
heterogeneity of tumor cells as the source of adaptation of cancer
to overcome the immune response, to become resistant to different
anti-cancer drugs, to invade adjacent tissues, and to produce metas-
tasis and invade other organs. According to mathematical models,
tumor benefits from a highly stable component: the cancer stem
cells (Solé et al., 2008), that might be considered analogous to a
master sequence in a viral quasispecies. In this view, tumor would
embody two components, a most variable one which explores phe-
notypes that allow the tumor to grow and persist, and the small
but also more robust component of cancer stem cells plays the
role of a reservoir of stability. This strategy would work as a life
insurance for the tumor, allowing progeny cells to mutate beyond
the limits established for normal cell types. The two-component
theory of tumor cells is reminiscent of the “pan-genome” in bac-
terial populations (Mira et al., 2010; Whitaker and Banfield, 2006).
While in a given bacterial species all its components share a core
component, subrepresentatives of the same species differ in part
of their genomic content. In other terms, the genome complement
of a bacterial species may  be larger than present in the individual
strains that constitute the species. As in the case of cancer cells, a
pan-genome type of population permits flexibility for adaptation
to changing environments. Indeed, horizontal gene transfers can
contribute to the construction of a non-core, adaptative portion
of the genome while preserving the core component that ensures
survival.
The highly diverse population generated during cancer cell
replication will allow the cellular ensemble to face diverse environ-
mental challenges, including immune responses and drugs used in
chemotherapy. It seems reasonable to anticipate that anti-cancer
drugs will fail when administered individually, even if they display
high potency (Luo et al., 2009). Great efforts have been assumed
from public and private institutions to achieve highly active anti-
cancer treatments (HAACT) or orthogonal therapy, the equivalent
to highly active antiretroviral therapy (HAART) used in HIV-1 ther-
apy (Luo et al., 2009). As in the case of variable RNA viruses, cancer
should be treated with therapies able to overcome the selection of
drug-resistant cells. In a clear parallel with the treatment of HIV-
1, sequential administration of anti-cancer compounds will most
likely result in treatment failure (Luo et al., 2009). Cancer therapies
are considered orthogonal, and therefore they act synergistically
when their anti-cancer activity is exerted in at least two different
ways, such that a suppressor mutation of the first therapy can-
not affect the second therapy, and vice versa. Because cancer is a
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ompilation of very different diseases (in the sense of triggering fac-
ors and resulting cellular phenotypes) the orthogonal therapy will
ary depending upon the tumor genotype and possibly the geno-
ype of the patient. Furthermore, because cancer therapies often
mply DNA damage, they may  increase the rate of emergence of
umor suppressor mutators. As an additional parallelism with RNA
iruses, lethal mutagenesis has been proposed as a novel thera-
eutic approach for the treatment of solid tumors (Fox and Loeb,
010).
We have extended the discussion of collective behavior of
acteria and cancer cells to illustrate the broad implications of
uasispecies theory regarding the concept of unit of selection. As
urprising as it may  appear, even non-genetic systems may  display
ollective, Darwinian behavior, as suggested by some recent results
ith prions (only-protein pathogenic agents) which are summa-
ized next.
. Molecular quasispecies again. The case of prions
Quasispecies theory was developed as a principle of self-
rganization of early life forms (Section 1) and it has since been
ssociated with nucleic acids as conveyers of genetic informa-
ion. However, other non-genetic macromolecular systems can also
isplay heterogeneity regarding features that are key to their bio-
ogical function. Recent developments in prion diseases offer a
triking example. Prions are infectious agents composed only of
rotein, and are the causative agents of scrapie and other neurode-
enerative diseases, as first proposed by Alper and Griffith (Alper
t al., 1967; Griffith, 1967), and then confirmed in the seminal work
y Prusiner and colleagues (Bolton et al., 1982; Prusiner, 1982).
rions propagate by transmitting a misfolded protein state of a cell-
oded protein. The protein-only hypothesis of prion propagation
as controversial until accumulation of evidence that included the
escription of prions generated in vitro (Castilla et al., 2005), as
ell as their propagation and further characterization in cell-free
nvironments (Barria et al., 2009; Castilla et al., 2008), has basically
ettled the issue.
The recent discovery of fungal prions not associated with dis-
ase suggests that prions could constitute a new and widespread
egulatory mechanism maintained through evolution (Jarosz et al.,
010; Tuite and Serio, 2010; Tyedmers et al., 2008). In parallel
ith viral quasispecies, prions cloned by end point dilution in
ell culture can gradually become heterogeneous by accumulating
rotein-folding “mutants” (Li et al., 2010). Furthermore, selective
ressures resulted in the emergence of variants, including drug-
esistant mutants (Ghaemmaghami et al., 2009; Li et al., 2010;
ahal et al., 2010). These results suggest that not only nucleic-
cid base systems can show high population heterogeneity, and
an experience selective events. A protein defined by a primary
tructure can be folded in different ways, each one associated with
 different phenotype that can be selected and further propagated.
n striking similarity with nucleic acid-based replicative ensembles,
rion populations show high population size and conformation het-
rogeneity, and recent results suggest that such heterogeneity may
nderlie selection and propagation capacity, a typical Darwinian
ehavior. How a population of this type evolves either as a sum of
ts components or only as molecular individualities is still largely
nknown (Straub and Thirumalai, 2011).
It may  seem surprising that a non-replicative feature such as
rotein conformation may  display quasispecies behavior, the appli-
ation of a theory intended to address genetic systems. However,
his is not that unexpected when the ultimate molecular basis of
rror-prone replication of nucleic acids is considered. Mutations
re the consequence of elementary events (molecular fluctuations)
ubjected to quantum mechanical uncertainty (Domingo et al.,rch 162 (2011) 203– 215 211
1995, 2001; Eigen, 1971). Protein conformation is the final result of
multiple amino acid–amino acid interactions themselves subjected
to molecular fluctuations such as ionization and ionic interaction or
hydrophobic contacts dependent on torsion angles of bonds which
are also subjected to thermal fluctuations. Thus, it is not unex-
pected that a collection of related but non-identical conformations
exist in any populations of proteins and that environmental factors
may  favor some conformations over others. The environment may
also dictate the presence of minority conformations at different fre-
quencies. Transitions among related conformation states in prions
became apparent because they affect a critical trait from the point
of view of human perception: disease capacity. These observations
open new prospects of research on the molecular mechanisms of
protein aggregation and whether a specific conformation variant
can nucleate the conversion of additional representatives of that
particular variant to form mutant aggregates (as a discussion of the
physico-chemical basis of protein aggregation and current research
problems, see Bernacki and Murphy, 2009 and references quoted
therein).
7. Concluding remarks
The adaptive capacity of RNA viruses has found a direct inter-
pretation in their populations adhering to quasispecies dynamics.
Early objections to quasispecies being adequate to interpret RNA
virus behavior, namely that the depth of the mutant spectrum was
overestimated due to in vitro RNA amplification errors and that
classic genetics was sufficient to explain virus behavior, have been
totally dispelled by two  lines of evidence. One is the introduc-
tion of ultra deep sequencing techniques that have confirmed the
great complexity of mutant spectra previously evidenced by Sanger
sequencing of biological and molecular clones of viruses. The other
is the recognition of internal interactions within quasispecies that
render classic Fisher–Wright formulations incomplete. The collec-
tive behavior of viruses, cell and macromolecular collectivities has
been the main emphasis of this review. How such behavior can be
mastered as antiviral, antibacterial, anticancer or antiprion strate-
gies remains a great challenge for the XXIst century, that should
ideally be approached by combining experimental and theoretical
research with a highly transdisciplinary flavor.
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